Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus

Experimental and Therapeutic Medicine

Volumn 5, Issue 4, 2013, Pages 1219-1225

  Zhu, Xiaohua ^a   Li, Feng ^a   Yang, Bo ^a   Liang, Jun ^a   Qin, Haihong ^a   Xu, Jinhua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

DNA methylation; DNA methyltransferase 1; Lupus erythematosus; Methyl CpG binding domain protein 2; Systemic

Indexed keywords

5 METHYLCYTOSINE; DNA METHYLTRANSFERASE 1; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRRADIATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET B RADIATION;

EID: 84874604354     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.960     Document Type: Article

References (48)

1. Sestak AL, Nath SK, Sawalha AH and Harley JB: Current status of lupus genetics. Arthritis Res Ther 9: 210, 2007.
2. Jönsen A, Bengtsson AA, Nived O, Truedsson L and Sturfelt G: Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity 40: 613-617, 2007.
3. Attwood JT, Yung RL and Richardson BC: DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 59: 2 41-257, 2002.
4. Richardson BC: Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 132 (8 Suppl): 2401S-2405S, 2002.
5. Richardson BC, Strahler JR, Pivirotto TS, et al: Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythe-matosus. Arthritis Rheum 35: 647-662, 1992.
6. Yung R, Powers D, Johnson K, et al: Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest 97: 2866-2871, 1996.
7. + T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is suffcient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92: 38-53, 1993.
8. + lupus T cells. J Immunol 172: 3652-3661, 2004.
9. Lu Q, Ray D, Gutsch D and Richardson B: Effect of DNA meth-ylation and chromatin structure on ITGAL expression. Blood 99: 4503-4508, 2002.
10. Nakao M: Epigenetics: interaction of DNA methylation and chromatin. Gene 278: 25-31, 2001.
11. Richardson B and Yung R: Role of DNA methylation in the regulation of cell function. J Lab Clin Med 134: 333-340, 1999.
12. Detich N, Theberge J and Szyf M: Promoter-specifc activation and demethylation by MBD2/demethylase. J Biol Chem 277: 35791-35794, 2002.
13. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classifcation of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.
14. Wysenbeek AJ, Block DA and Fries JF: Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann Rheum Dis 48: 461-463, 1989.
15. Lehmann P, Hölzle E, Kind P, Goerz G and Plewig G: Experimental reproduction of skin lesions in lupus erythe-matosus by UVA and UVB radiation. J Am Acad Dermatol 22: 181-187, 1990.
16. Bombardier C, Gladman DD, Urowitz MB, Caron D and Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35: 630-640, 1992.
17. WHO: Global Solar UV Index: A Practical Guide. World Health Organization, Geneva, Switzerland, 2002.
18. Gies P: Australia has more than enough solar UV radiation. Clin Exp Optom 86: 71-73, 2003.
19. Habib M, Fares F, Bourgeois CA, et al: DNA global hypometh-ylation in EBV-transformed interphase nuclei. Exp Cell Res 249: 46-53, 1999.
20. Milutinovic S, Zhuang Q, Niveleau A and Szyf M: Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 278: 14985-14995, 2003.
21. Wang X and Seed B: A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31: e154, 2003.
22. Fuke C, Shimabukuro M, Petronis A, et al: Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 68: 196-204, 2004.
23. Klinman DM, Mushinski JF, Honda M, et al: Oncogene expression in autoimmune and normal peripheral blood mono-nuclear cells. J Exp Med 163: 1292-1307, 1986.
24. Tsokos GC and Kammer GM: Molecular aberrations in human systemic lupus erythematosus. Mol Med Today 6: 418-424, 2000.
25. Surani MA: Imprinting and the initiation of gene silencing in the germ line. Cell 93: 309-312, 1998.
26. Ng HH and Bird A: DNA methylation and chromatin modif-cation. Curr Opin Genet Dev 9: 158-163, 1999.
27. Knight SJ, Flannery AV, Hirst MC, et al: Trinucleotide repeat amplifcation and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74: 127-134, 1993.
28. Xu GL, Bestor TH, Bourc'his D, et al: Chromosome instability and immunodefciency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187-191, 1999.
29. Yung R, Chang S, Hemati N, Johnson K and Richardson B: Mechanisms of drug-induced lupus. I V. Comparison of procainamide and hydralazine with analogs in vitro and in vivo. Arthritis Rheum 40: 1436-1443, 1997.
30. Yung RL, Quddus J, Chrisp CE, Johnson KJ and Richardson BC: Mechanism of drug-induced lupus. I. Cloned Th2 cells modifed with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 154: 3025-3035, 1995.
31. Sawalha AH and Richardson B: DNA methylation in the pathogenesis of systemic lupus erythematosus. Curr Pharmacogenomics 3: 73-78, 2005.
32. Deng C, Yang J, Scott J, Hanash S and Richardson BC: Role of the ras-MAPK signaling pathway in the DNA methyltransferase response to DNA hypomethylation. Biol Chem 379: 1113-1120, 1998.
33. Okano M, Xie S and Li E: Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltrans-ferases. Nat Genet 19: 219-220, 1998.
34. Ogasawara H, Okada M, Kaneko H, Hishikawa T, Sekigawa I and Hashimoto H: Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses. Clin Exp Rheumatol 21: 733-738, 2003.
35. Vertino PM, Yen RW, Gao J and Baylin SB: De novo methylation of CpG island sequences in human fbroblasts overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol 16: 4555-4565, 1996.
36. Fan G and Hutnick L: Methyl-CpG binding proteins in the nervous system. Cell Res 15: 255-261, 2005.
37. Klose RJ and Bird AP: Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97, 2006.
38. Bhattacharya SK, Ramchandani S, Cervoni N and Szyf M: A mammalian protein with specifc demethylase activity for mCpG DNA. Nature 397: 579-583, 1999.
39. Ng HH, Zhang Y, Hendrich B, et al: MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 23: 58-61, 1999.
40. Kastan MB, Gowans BJ and Lieberman MW: Methylation of deoxycytidine incorporated by excision-repair synthesis of DNA. Cell 30: 509-516, 1982.
41. Lieberman MW, Beach LR and Palmiter RD: Ultraviolet radiation-induced metallothionein-I gene activation is associated with extensive DNA demethylation. Cell 35: 207-214, 1983.
42. Zhang Z, Deng C, Lu Q and Richardson B: Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter. Mech Ageing Dev 123: 1257-1268, 2002.
43. Balada E, Ordi-Ros J and Vilardell-Tarrés M: DNA methylation and systemic lupus erythematosus. Ann NY Acad Sci 1108: 127-136, 2007.
44. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S and Johnson M: Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33: 1665-1673, 1990.
45. Nyce J, Liu L and Jones PA: Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells. Nucleic Acids Res 14: 4353-4367, 1986.
46. Deng C, Kaplan MJ, Yang J, et al: Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 44: 397-407, 2001.
47. Yoder JA, Soman NS, Verdine GL and Bestor TH: DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. J Mol Biol 270: 385-395, 1997.
48. + T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 38: 369-374, 2009.